Six widely used dietary supplements promoted for improving heart health did not effectively lower LDL or “bad” cholesterol in comparison to a common low-dose statin medication or placebo, according to late breaking science results presented today at the American Heart Association’s Scientific Sessions 2022. The meeting, held in person in Chicago and virtually, Nov. 5–7, 2022, is a global exchange of the latest scientific advancements, research and evidence-based clinical practice updates in cardiovascular science.
Six common ‘heart-health’ supplements ineffective at lowering cholesterol compared to statins

Comments